S.AquaroS.et al (1997)
Survodutide and CagriSema are also in the pipeline
You may be eligible to use Semaglutide GLP-1 if your body mass index (BMI) is 30 kg/m or higher (obesity) or 27 kg/m or higher (overweight), and you have at least one weight-related health problem, such as high blood pressure, heart problems, type 2 diabetes, or insomnia
This is the start of a new chapter in their metamorphosis
De Bandt D, Rives-Lange C, Frigout Y, Bergerot D, Blanchard A, Le Gall M, et al
Semaglutide vs Tirzepatide for PCOS Summary If you have PCOS , Semaglutide and Tirzepatide can help by targeting multiple aspects of the condition: Weight and fat loss Better insulin control Reduced androgen symptoms Improved fertility and cycle regularity Many patients report improvements within 812 weeks , especially when combined with lifestyle changes like a high-protein, low-glycemic diet and strength training